Genpact Limited G
33.10
(0.27)
(0.81%)
as of 25 Sep
- Market cap
- $5.6B
- P/E
- 9.7×
Follow G
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
8.09 | 11.29 | 14.71 | 13.26 |
+8 more quarters Free account |
P/S ratio |
0.89 | 1.23 | 1.60 | 1.45 | |
P/FCF ratio |
8.42 | 9.74 | 11.23 | 11.27 | |
P/Operating CF |
64.18 | (269.55) | 28.37 | 23.58 | |
P/B ratio |
1.78 | 2.56 | 3.19 | 2.86 | |
Price to Tangible BV |
6.10 | 9.95 | 11.60 | 10.55 | |
EV/Sales |
1.01 | 1.35 | 1.67 | 1.54 | |
EV/EBITDA |
6.07 | 8.06 | 10.00 | 9.20 | |
EV/Operating CF |
8.25 | 9.28 | 10.42 | 10.60 | |
EV/FCF |
9.62 | 10.67 | 11.70 | 11.99 | |
Quick Ratio |
1.77 | 1.53 | 1.53 | 1.38 | |
Current Ratio |
2.00 | 1.69 | 1.66 | 1.51 | |
Net Debt/EBITDA |
3.10 | 2.76 | 1.52 | 2.12 | |
Debt/Assets |
21.80% | 27.35% | 26.39% | 22.43% | |
Debt/Equity |
0.45 | 0.62 | 0.61 | 0.47 | |
Asset Turnover |
0.98 | 0.98 | 0.94 | 0.94 | |
Operating CF/Net income |
0.50 | (0.16) | 2.00 | 2.11 | |
Capex/Depreciation |
(0.89) | (1.45) | (0.82) | (0.73) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.89% | 20.86% | 21.01% | 20.30% | |
Intangible Assets out of Total Assets |
0.34 | 0.33 | 0.32 | 0.35 | |
Share Based Compensation of Revenue |
1.96% | 1.72% | 1.94% | 1.72% | |
Graham Net Nets |
(0.14) | (0.12) | (0.08) | (0.08) | |
Graham Number |
34.33 | 32.85 | 32.39 | 32.28 | |
Earnings Yield |
12.36% | 8.86% | 6.80% | 7.54% | |
Free Cash Flow Yield |
11.88% | 10.27% | 8.90% | 8.87% | |
Revenue per Share |
7.95 | 7.61 | 7.59 | 7.44 | |
Operating CF per Share |
0.43 | (0.14) | 1.65 | 1.78 | |
Capex per Share |
(0.11) | (0.18) | (0.13) | (0.11) | |
Free Cash Flow per Share |
0.32 | (0.32) | 1.52 | 1.66 | |
Cash per Share |
3.06 | 5.45 | 6.92 | 4.27 | |
Shareholders Equity per Share |
15.41 | 14.53 | 14.66 | 14.66 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
15.41 | 14.53 | 14.66 | 14.66 | |
Free Cash Flow |
53.66 | (54.98) | 264.84 | 288.91 | |
Working Capital |
1,082.99 | 979.00 | 1,053.89 | 750.85 | |
Capital Expenditures |
(18.78) | (31.45) | (21.86) | (19.45) | |
Net Current Asset Value |
(637.54) | (736.79) | (637.50) | (607.13) | |
EV/EBIT |
6.82 | 9.09 | 11.29 | 10.38 | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
10.85% | 11.42% | 10.85% | 11.29% | |
Price to Operating Income |
5.97 | 8.29 | 10.84 | 9.76 | |
| Other line items | |||||
Average Receivables |
1,334.73 | 1,226.01 | 1,219.58 | 1,247.52 | |
Average Payables |
30.02 | 31.76 | 32.00 | 26.65 | |
Average Assets |
5,360.39 | 5,256.10 | 5,415.21 | 5,344.91 | |
Average Common Equity |
2,595.70 | 2,464.13 | 2,469.51 | 2,469.61 |
Columns are period end dates